Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

HPV-009 Treatment Allocations- Cervarix, October 2, 2007

To: Mr. Matthew Whitman
File: STN 125259/0 CERVARIX
RE: HPV-009 – Treatment Allocations
Date: October 2, 2007

Please refer to study HPV-009. We have previously requested the treatment allocations for four subjects who developed rheumatoid arthritis in HPV-009. In review of the meta-analysis for potentially autoimmune events, there was noted to be five subjects (PID numbers 105646, 123422, 229946, 216829, and 230320) who developed rheumatoid arthritis. In addition, one subject (PID number 185015) developed erythema nodosum, one subject (PID number 302971) developed ulcerative colitis, and two subjects (PID numbers 323356 and 165709) developed inflammatory bowel disease. We acknowledge that the study is ongoing, but please provide the treatment allocations for these subjects by the unblinded statistician as soon as possible.

Page Last Updated: 04/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English